Table 4.
|
|
|
Treatment |
Control |
|
|
||
---|---|---|---|---|---|---|---|---|
Comparison | Site | Date | Samples | Nymphs (SD) | Samples | Nymphs (SD) | Weight | Effect size |
1 | RI | 5/30–6/15/00 | 15 | 31.9 (0.8) | 15 | 58.3 (3.0) | 7.0 | −0.77 |
2 | RI | 6/21–7/6/00 | 15 | 33.7 (1.0) | 15 | 45.4 (2.3) | 7.3 | −0.43 |
3 | RI | 7/17–7/24/00 | 15 | 30.5 (1.1) | 15 | 41.2 (2.1) | 7.3 | −0.41 |
4 | RI | 8/6–8/23/00 | 15 | 46.2 (2.5) | 15 | 57.2 (2.9) | 7.4 | −0.27 |
5 | CT | 5/22/00 | 15 | 48 (3) | 12 | 74 (6) | 6.4 | −0.63 |
6 | CT | 6/5/00 | 15 | 122 (8) | 12 | 47 (3) | 6.4 | 0.62 |
7 | CT | 6/19–6/22/00 | 15 | 76 (4) | 12 | 94 (6) | 6.4 | −0.55 |
8 | CT | 7/3/00 | 15 | 48 (3) | 12 | 80 (5) | 6.1 | −0.83 |
9 | CT | 7/17/00 | 15 | 39 (2) | 12 | 88 (6) | 5.8 | −1.07 |
10 | CT | 7/31–8/1/00 | 13 | 19 (2) | 12 | 18 (2) | 6.2 | −0.02 |
11 | NY | 5/25–6/2/00 | 13 | 30.1 (1.5) | 11 | 35.1 (1.8) | 5.8 | −0.51 |
12 | NY | 6/20–6/28/00 | 21 | 18.5 (0.8) | 13 | 14.1 (0.8) | 8.0 | −0.26 |
13 | NJ | 5/24/00 | 25 | 28 (1) | 20 | 102 (6) | 9.9 | −1.02 |
14 | NJ | 5/30/00 | 25 | 46 (2) | 20 | 74 (4) | 10.6 | −0.64 |
15 | NJ | 6/8/00 | 25 | 35 (2) | 20 | 114 (6) | 9.9 | −1.00 |
16 | NJ | 6/15/00 | 25 | 59 (2) | 20 | 91 (4) | 10.6 | −0.65 |
17 | MD | 6/4/01 | 15 | 126 (8) | 15 | 262.1 (12.4) | 6.9 | −0.85 |
18 | MD | 6/11/01 | 15 | 109 (8) | 15 | 406.6 (16.9) | 5.9 | −1.45 |
19 | MD | 6/18/01 | 15 | 101 (6) | 15 | 357.0 (18.2) | 6.3 | −1.23 |
20 | MD | 6/26/01 | 15 | 61 (3) | 15 | 341.6 (17.7) | 6.0 | −1.44 |
SD, standard deviation.